Ovarian morphology in premenstrual dysphoria

Psychoneuroendocrinology

Volumn 37, Issue 6, 2012, Pages 742-751

  Eriksson, Olle ^a   Landén, Mikael ^b   Sundblad, Charlotta ^c   Holte, Jan ^d   Eriksson, Elias ^c   Naessén, Tord ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d Carl von Linne Clinic   (Sweden)

Author keywords

PCO; PMDD; Premenstrual syndrome; Testosterone; Transvaginal ultrasonography

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; IRRITABILITY; LUTEAL PHASE; OVARY; OVARY POLYCYSTIC DISEASE; POST HOC ANALYSIS; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TOTAL NUMBER OF FOLLICLE; TOTAL OVARIAN VOLUME; TRANSVAGINAL ECHOGRAPHY; UROGENITAL SYSTEM PARAMETERS; VENOUS BLOOD;

ADULT; AFFECT; ANDROGENS; ANTHROPOMETRY; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; IRRITABLE MOOD; LUTEINIZING HORMONE; OVARIAN FOLLICLE; OVARY; OVULATION; POLYCYSTIC OVARY SYNDROME; PREMENSTRUAL SYNDROME; QUESTIONNAIRES; SEX HORMONE-BINDING GLOBULIN;

EID: 84859878926     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.09.005     Document Type: Article

References (69)

1. Adams J., Franks S., Polson D.W., Mason H.D., Abdulwahid N., Tucker M., Morris D.V., Price J., Jacobs H.S. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985, 2:1375-1379.
2. Angst J., Sellaro R., Merikangas K.R., Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr. Scand. 2001, 104:110-116.
3. APA Diagnostic and Statistical Manual of Mental Disorders 1994, APA Press, Washington, DC.
4. Azziz R., Carmina E., Sawaya M.E. Idiopathic hirsutism. Endocr. Rev. 2000, 21:347-362.
5. Backstrom T., Aakvaag A. Plasma prolactin and testosterone during the luteal phase in women with premenstrual tension syndrome. Psychoneuroendocrinology 1981, 6:245-251.
6. Backstrom T., Wide L., Sodergard R., Carstensen H. FSH, LH, TeBG-capacity, estrogen and progesterone in women with premenstrual tension during the luteal phase. J. Steroid Biochem. 1976, 7:473-476.
7. Baischer W., Koinig G., Hartmann B., Huber J., Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology 1995, 20:553-559.
8. Bancroft J., Boyle H., Warner P., Fraser H.M. The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes. Clin. Endocrinol. (Oxf.) 1987, 27:171-182.
9. Barnard L., Ferriday D., Guenther N., Strauss B., Balen A.H., Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum. Reprod. 2007, 22:2279-2286.
10. Behre H.M., Kuhlage J., Gassner C., Sonntag B., Schem C., Schneider H.P., Nieschlag E. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum. Reprod. 2000, 15:2478-2482.
11. Benson S., Arck P.C., Tan S., Hahn S., Mann K., Rifaie N., Janssen O.E., Schedlowski M., Elsenbruch S. Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology 2009, 34:727-735.
12. Bloch M., Schmidt P.J., Su T.P., Tobin M.B., Rubinow D.R. Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls. Biol. Psychiatry 1998, 43:897-903.
13. Blum I., Lerman M., Misrachi I., Nordenberg Y., Grosskopf I., Weizman A., Levy-Schiff R., Sulkes J., Vered Y. Lack of plasma norepinephrine cyclicity, increased estradiol during the follicular phase, and of progesterone and gonadotrophins at ovulation in women with premenstrual syndrome. Neuropsychobiology 2004, 50:10-15.
14. Botsis D., Kassanos D., Pyrgiotis E., Zourlas P.A. Sonographic incidence of polycystic ovaries in a gynecological population. Ultrasound Obstet. Gynecol. 1995, 6:182-185.
15. Bromberger J.T., Schott L.L., Kravitz H.M., Sowers M., Avis N.E., Gold E.B., Randolph J.F., Matthews K.A. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch. Gen. Psychiatry 2010, 67:598-607.
16. Buckler H.M., McElhone K., Durrington P.N., Mackness M.I., Ludlam C.A., Wu F.C. The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women. Clin. Endocrinol. (Oxf.) 1998, 49:173-178.
17. Casper R.F., Hearn M.T. The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome. Am. J. Obstet. Gynecol. 1990, 162:105-109.
18. Casson P., Hahn P.M., Van Vugt D.A., Reid R.L. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am. J. Obstet. Gynecol. 1990, 162:99-105.
19. Clayton R.N., Ogden V., Hodgkinson J., Worswick L., Rodin D.A., Dyer S., Meade T.W. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?. Clin. Endocrinol. (Oxf.) 1992, 37:127-134.
20. Cronje W.H., Vashisht A., Studd J.W. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum. Reprod. 2004, 19:2152-2155.
21. Cubeddu A., Bucci F., Giannini A., Russo M., Daino D., Russo N., Merlini S., Pluchino N., Valentino V., Casarosa E., Luisi S., Genazzani A.R. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology 2011, 36:523-530.
22. Deeks A.A., Gibson-Helm M.E., Teede H.J. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil. Steril. 2010, 93:2421-2423.
23. DePriest P.D., van Nagell J.R., Gallion H.H., Shenson D., Hunter J.E., Andrews S.J., Powell D.E., Pavlik E.J. Ovarian cancer screening in asymptomatic postmenopausal women. Gynecol. Oncol. 1993, 51:205-209.
24. Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev. Mol. Med. 2008, 10:e3.
25. Dokras A., Clifton S., Futterweit W., Wild R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet. Gynecol. 2011, 117:145-152.
26. Dougherty D.M., Bjork J.M., Moeller F.G., Swann A.C. The influence of menstrual-cycle phase on the relationship between testosterone and aggression. Physiol. Behav. 1997, 62:431-435.
27. Eaker, S., 2003. Optimization of compliance in epidemiologic research and disease prevention: with special emphasis on PAP-smear screening. Doctoral Thesis. Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
28. Eriksson E., Alling C., Andersch B., Andersson K., Berggren U. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Neuropsychopharmacology 1994, 11:201-213.
29. Eriksson E., Andersch B., Ho H.P., Landen M., Sundblad C. Diagnosis and treatment of premenstrual dysphoria. J. Clin. Psychiatry 2002, 63(Suppl. 7):16-23.
30. Eriksson E., Sundblad C., Lisjo P., Modigh K., Andersch B. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 1992, 17:195-204.
31. Eriksson O., Backstrom T., Stridsberg M., Hammarlund-Udenaes M., Naessen T. Differential response to estrogen challenge test in women with and without premenstrual dysphoria. Psychoneuroendocrinology 2006, 31:415-427.
32. Farquhar C.M., Birdsall M., Manning P., Mitchell J.M. Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries in a population of randomly selected women. Ultrasound Obstet. Gynecol. 1994, 4:54-59.
33. Freeman E.W., Sammel M.D., Lin H., Gracia C.R., Kapoor S. Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet. Gynecol. 2008, 111:127-136.
34. Gibreel A., Maheshwari A., Bhattacharya S., Johnson N.P. Ultrasound tests of ovarian reserve; a systematic review of accuracy in predicting fertility outcomes. Hum. Fertil. (Camb.) 2009, 12:95-106.
35. Hammarback S., Backstrom T. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstet. Gynecol. Scand. 1988, 67:159-166.
36. Hart R., Hickey M., Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol. 2004, 18:671-683.
37. Hartlage S.A., Arduino K.E. Toward the content validity of premenstrual dysphoric disorder: do anger and irritability more than depressed mood represent treatment-seekers' experiences?. Psychol. Rep. 2002, 90:189-202.
38. Himelein M.J., Thatcher S.S. Polycystic ovary syndrome and mental health: a review. Obstet. Gynecol. Surv. 2006, 61:723-732.
39. Hollinrake E., Abreu A., Maifeld M., Van Voorhis B.J., Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil. Steril. 2007, 87:1369-1376.
40. Holte J.G. Biotechnology of Human Reproduction 2002, vol. 4:3-56. Parthenon Publishing Group, London.
41. Iurassich S., Trotta C., Palagiano A., Pace L. Correlations between acne and polycystic ovary. A study of 60 cases. Minerva Ginecol. 2001, 53:107-111.
42. Jedel E., Waern M., Gustafson D., Landen M., Eriksson E., Holm G., Nilsson L., Lind A.K., Janson P.O., Stener-Victorin E. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum. Reprod. 2009, 25:450-456.
43. Lakhani K., Seifalian A.M., Atiomo W.U., Hardiman P. Polycystic ovaries. Br. J. Radiol. 2002, 75:9-16.
44. Landen M., Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders?. Depress. Anxiety 2003, 17:122-129.
45. Landen M., Eriksson O., Sundblad C., Andersch B., Naessen T., Eriksson E. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. Psychopharmacology (Berl.) 2001, 155:292-298.
46. Lombardi I., Luisi S., Quirici B., Monteleone P., Bernardi F., Liut M., Casarosa E., Palumbo M., Petraglia F., Genazzani A.R. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol. Endocrinol. 2004, 18:79-87.
47. Lowe P., Kovacs G., Howlett D. Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia. Aust. NZ. J. Obstet. Gynaecol. 2005, 45:17-19.
48. Mansson M., Holte J., Landin-Wilhelmsen K., Dahlgren E., Johansson A., Landen M. Women with polycystic ovary syndrome are often depressed or anxious: a case control study. Psychoneuroendocrinology 2008, 33:1132-1138.
49. May K. Home tests to monitor fertility. Am. J. Obstet. Gynecol. 1991, 165:2000-2002.
50. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
51. Muse K.N., Cetel N.S., Futterman L.A., Yen S.C. The premenstrual syndrome. Effects of medical ovariectomy. N. Engl. J. Med. 1984, 311:1345-1349.
52. Norman R.J., Dewailly D., Legro R.S., Hickey T.E. Polycystic ovary syndrome. Lancet 2007, 370:685-697.
53. Pearlstein T., Yonkers K.A., Fayyad R., Gillespie J.A. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J. Affect. Disord. 2005, 85:275-282.
54. Rapkin A.J. YAZ in the treatment of premenstrual dysphoric disorder. J. Reprod. Med. 2008, 53:729-741.
55. Roepke S., Ziegenhorn A., Kronsbein J., Merkl A., Bahri S., Lange J., Lubbert H., Schweiger U., Heuser I., Lammers C.H. Incidence of polycystic ovaries and androgen serum levels in women with borderline personality disorder. J. Psychiatr. Res. 2010, 44:847-852.
56. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J. Clin. Endocrinol. Metab. 2007, 92:405-413.
57. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 2004, 81(1):19-25.
58. Rubinow D.R., Hoban M.C., Grover G.N., Galloway D.S., Roy-Byrne P., Andersen R., Merriam G.R. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am. J. Obstet. Gynecol. 1988, 158:5-11.
59. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Engl. J. Med. 1998, 338:209-216.
60. Seifer D.B., Feng B., Shelden R.M., Chen S., Dreyfus C.F. Brain-derived neurotrophic factor: a novel human ovarian follicular protein. J. Clin. Endocrinol. Metab. 2002, 87:655-659.
61. Seifer D.B., Feng B., Shelden R.M., Chen S., Dreyfus C.F. Neurotrophin-4/5 and neurotrophin-3 are present within the human ovarian follicle but appear to have different paracrine/autocrine functions. J. Clin. Endocrinol. Metab. 2002, 87:4569-4571.
62. Seippel L., Backstrom T. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J. Clin. Endocrinol. Metab. 1998, 83:1988-1992.
63. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33. quiz 34-57.
64. Smith M.J., Schmidt P.J., Su T.P., Rubinow D.R. Gonadotropin-releasing hormone-stimulated gonadotropin levels in women with premenstrual dysphoria. Gynecol. Endocrinol. 2004, 19:335-343.
65. Souter I., Sanchez L.A., Perez M., Bartolucci A.A., Azziz R. The prevalence of androgen excess among patients with minimal unwanted hair growth. Am. J. Obstet. Gynecol. 2004, 191:1914-1920.
66. Steiner M., Peer M., Palova E., Freeman E.W., Macdougall M., Soares C.N. The Premenstrual Symptoms Screening Tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents. Arch. Womens Ment. Health. 2011, 14:77-81.
67. Watts J.F., Butt W.R., Logan Edwards R., Holder G. Hormonal studies in women with premenstrual tension. Br. J. Obstet. Gynaecol. 1985, 92:247-255.
68. Wyatt K.M., Dimmock P.W., Ismail K.M., Jones P.W., O'Brien P.M. The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis. BJOG 2004, 111:585-593.
69. Yonkers K.A., O'Brien P.M., Eriksson E. Premenstrual syndrome. Lancet 2008, 371:1200-1210.